We report the isolation and complete structure of an isomer of rebaudioside D, known as rebaudioside D2. This novel steviol glycoside was isolated from a bioconversion reaction of rebaudioside A to rebaudioside D. Rebaudioside D2 possesses a relatively rare 1→6 sugar linkage, which was discovered by extensive analysis of NMR ( 1 H, 13 C, COSY, HSQC-DEPT, HMBC, 1D TOCSY and NOESY) and mass spectral data.
In recent years the need for novel natural sweeteners has increased due to the consumer's desire to control more closely caloric intake. To address this challenge, we have investigated a family of steviol glycosides isolated from Stevia rebaudiana Bertoni for their ability to sweeten products and provide no caloric content [1] . Extracts of the leaves have traditionally been used to sweeten local teas and medicines in Paraguay and Brazil [2] . Over the past few decades, S. rebaudiana leaves have been the source of isolation of a large number of steviol glycosides with varying molecular structures [3] . The most abundant steviol glycosides found in S. rebaudiana with an ent-kaurane-type diterpene core are: steviolbioside, stevioside, rebaudioside A-F, ducoside A and rubusoside [4] .
Sweet steviol glycosides possess a sensory characteristic superior to other high potency sweeteners [5] [6] . Rebaudioside A is the most successful commercially to date because of its high abundance in the leaves, stability, and sweet taste profile [6] [7] . Most recently we have reported the isolation and full characterization of rebaudioside M (1), a novel steviol glycoside from S. rebaudiana (Figure 1) [8] . A wide variety of sensory evaluations of rebaudioside M determined its flavor characteristics as clean, with a sweet taste, and a less bitter after taste than rebaudioside A [9] .
We showed previously that minor products from the bioconversion reaction of rebaudioside A (3) to rebaudioside D (4) have enabled the discovery of novel steviol glycosides, such as rebaudioside M2 (2), shown in Figure 1 [10] . In the present study, we report the discovery of rebaudioside D2 (5), an additional minor product from the bioconversion reaction of rebaudioside A to rebaudioside D ( Figure 2 ). Herein we present the isolation, characterization, and complete 1 H and 13 C NMR spectral assignments for (13- ester]), also known as rebaudioside D2. Rebaudioside D2 (5) is an isomer of rebaudioside D (4) and contains a relatively rare 1→6 sugar linkage similar to rebaudioside M2 (2) .
The bioconversion reaction was analyzed by HPLC with reference standards (Table 1) . Rebaudioside D2 (5) was identified as a side Having estiblished the molecular weight of the compound, 1D and 2D NMR data were used to determine the presence of a glycoside structure having a central diterpene core with five sugars. The 1 H NMR spectrum and the HSQC-DEPT data of 5 indicated the presence of two methyl singlets at δ 1.29 and 1.30, two olefinic proton singlets corresponding to an exocyclic double bond at δ H 5.01 and 5.64, nine methylene, and two methine protons between δ H 0.75-2.65 characteristic for the central diterpenoid core (Table 1) . .6)], confirmed the presence of five sugar units in the structure. The complete assembly of the glycoside structure was made on the basis of correlations observed in the 2D and 1D TOCSY NMR data. Thus, long range 1 H-13 C correlations observed in the HMBC experiment from the anomeric proton at δ H 6.02 to a carbonyl carbon at δ C 177.7 (C-19) allowed its assignment as the anomeric proton (H-1') of sugar I. Similarly, HMBC correlation from the anomeric proton observed at δ H 5.07 to a quaternary carbon at δ C 87.1 (C-13) allowed it to be assigned as the anomeric proton (H-1'') of sugar II (Figure 3 ).
NPC Natural Product
Further analysis of the 1D and 2D NMR data allowed the assignment of the remaining three sugars in 5. The relatively downfield chemical shift of C-6' (δ C 69.9) in sugar I suggested a 6-O-branched-D-glucodiosyl substituent at C-19. Long range 1 H-13 C correlations observed in the HMBC experiment from the anomeric proton observed at δ H 5.04 (H-1''''') to the carbon at δ C 69.9 (C-6') and from H-6' at δ H 4.30 to an anomeric carbon at δ C 105.6 (C-1''''') confirmed the presence of a 1→6 sugar linkage between sugar V and sugar I.
The remaining two glucose moieties were assigned in a similar manner. The relatively downfield chemical shift of C-2'' (δ C 81.3) and C-3'' (δ C 88.4) in sugar II suggested a 2,3-branched-Dglucotriosyl substituent at C-13. Long range 1 H-13 C correlations observed in the HMBC experiment from the anomeric proton observed at δ H 5.57 (H-1''') to the carbon at δ C 81.3 (C-2'') and from H-2'' at δ H 4.37 to an anomeric carbon at δ C 105.3 (C-1''') confirmed the sugar substitution at C-2'' in sugar II. Similarly, the sugar substituent at C-3'' in sugar II was also corroborated by HMBC correlations observed from the anomeric proton at δ H 5.34 (H-1'''') to the carbon at δ C 88.4 (C-3'') and from H-3'' at δ H 4.18 to the anomeric carbon (δ C 105.3) of sugar IV confirmed the presence of a 1→3 sugar linkage between sugar IV and sugar II. 5.34 (d, J = 7.9 Hz) and δ H 5.04 (d, J = 8.1 Hz), suggested their βorientation. The remaining anomeric proton at δ H 5.07 was obscured by the solvent resonance (HDO), but its coupling constant (J = ~8 Hz), evident from 1D TOCSY data, also indicated β-orientation.
The 1 H and 13 C chemical shifts for the glycoside at C-13 and C-19 are found in Table 1 and a summary of the key HMBC, COSY, and 1D-TOCSY correlations used to assign the glycoside are provided in Figure 3 .
Correlations observed in the NOESY spectrum were used to assign the relative stereochemistry of the central diterpene core. In the NOESY spectrum, NOE correlations were observed between H-14 and H-20 indicating that H-14 and H-20 are on the same face of the rings. Similarly, NOE correlations were observed between H-9 and H-5 and H-9 and H-18, as well as H-5 and H-18, but NOE correlations were not observed between H-9 and H-14 indicating that H-5, H-9 and H-18 were on the opposite face of the rings compared with H-14 and H-20, as presented in Figure 3 . The carbon chemical shifts also support the relative stereochemistry as presented in Figure 3 [8, 11] . These data thus indicated that the relative stereochemistry was retained during the glycosylation step.
Thus the structure of rebaudioside D2 (5) Analyses of the semi-preparative purification fractions were performed using the following method: Waters Atlantis dC18, 4.6 × 100 mm, 5 μm (p/n 186001340); mobile phase A: 25% MeCN in water; mobile phase B: 30% MeCN in water; flow rate: 1.0 mL/min; injection volume: 10 μL, detection by CAD. Gradient: 0-5 min (100A), 20 -25 min (20A:80B), 30 min (100A). 
Experimental

Isolation of rebaudioside D2 from bioconversion reaction of rebaudioside A to rebaudioside D:
LC-MS:
Isolation of 5 by HPLC:
The purification was performed in 2 chromatographic steps. The first method used for the semi-preparative purification is summarized below. Column: Waters Atlantis dC18, 30 × 100 mm, 5 µm (p/n 186001375); mobile phase A: 25% MeCN in water; mobile phase B: 30% MeCN in water; flow rate: 45 mL/min; injection load: 160 mg dissolved in 20 mL of water. Detection was by UV (205 nm). Gradient: 0-5 min (100A), 20-25 min (20A:80B), 30 min (100A). The secondary purification used the same column and conditions, but isocratic mobile phase: 20% MeCN in water. Rebaudioside D2 (ca. 2 mg) was recovered from the eluent via rotary evaporation (Buchi R-114 Rotovapor) and lyophilization (FTS System benchtop lyophilizer).
Mass spectrometry:
The ESI-TOF mass spectra and MS/MS data were generated by a Waters QTof Premier mass spectrometer equipped with an electrospray ionization source. Samples were analyzed by negative ESI. Samples were diluted 50-fold with H 2 O: MeCN (1:1) and introduced via infusion using the onboard syringe pump.
NMR:
The sample was prepared by dissolving 1 -2 mg in 150 µL of pyridine-d 5 and NMR data were acquired on a Bruker Avance 500 MHz instrument (Bruker BioSpin Corporation, Billerica, MA, USA) with a 2.5 mm inverse detection probe and 5 mm broad band probe. The 1 H NMR spectrum was referenced to the residual solvent signal ( H 8.74 and  C 150.35 for pyridine-d 5 ).
Bioconversion reaction: Rebaudioside D2 (5) was isolated from the bioconversion reaction of rebaudioside A (3) to rebaudioside D (4) by a proprietary glucosyltransferase from PureCircle Ltd. In vivo production of glycosylation enzymes were expressed in yeast.
Rebaudioside A to rebaudioside D conversion with glucosyltransferase UGTSL2 experimental condition are as follows: 430 μL of a reaction mixture containing 0.5 mM rebaudioside A, 3 mM MgCl 2 , 50 mM sodium phosphate buffer at pH 7.2 and 2.5 mM of UDP-Glucose was added to a 1.5 mL sterile microtube. Fifty-two μL of the enzyme expressed medium was added and the resulting mixture was allowed to react at 30°C for 24 h. Samples (125 μL) were taken after 2 h, 16 h, and 24 h and added to 115 μL of 60% methanol and 10 μL of 2 N sulfuric acid. The quenched sample was centrifuged at 18,000× g for 2 min at room temperature. Two hundred μL was transferred to a HPLC vial and analyzed by the method described below.
HPLC analyses of samples were performed using an Agilent 1200 series HPLC system equipped with a binary pump (G1312B), autosampler (G1367D), thermostatted compartment (G13136B) and DAD detector (G1315C), connected with Agilent 6110 A MSD, and interfaced with "LC/MSD Chemstation" software. The conditions used were Phenomenex Kinetex, 2.6 μm C18 100A, 4.6 mm × 150 mm, 2.6 μm; column temp: 55 °C; mobile phase A: 0.1% formic acid in water; mobile phase B: acetonitrile (MeCN); flow rate: 1.0 mL/min; injection volume: 2 µL. Detection was by DAD (210 nm) and MSD (Scan and SIM mode, ES-API, negative polarity). Gradient: 0-8.5 min (75A:25B), 10 min (71A:29B), 16.5 min (70A:30B). SIM parameters 0-4.0 min (SIM ion 1289-1291), 4-11 min (SIM ion 1127-1290), 11-22 min (SIM ion 965-967). Supplementary data: 1D and 2D NMR spectra of compound 5 are included in the SI.
